Eli Lilly Launches Second Education Program for Medical Students
Eli Lilly and Company has launch of another medical student education program, an internship for aspiring physicians. The Lilly Medical Student Intern Program, the second phase of its medical student programs, offers opportunities for medical students between their first and second years to work alongside healthcare professionals in the pharmaceutical industry to gain scientific knowledge and experience in several areas, including preclinical research, clinical trial development, medical affairs, regulatory affairs, bio-ethics and patient safety.
Six students from Marian University College of Osteopathic Medicine will be the first to participate in the intern program at Eli Lilly and Company's Indianapolis headquarters. Students will expand their knowledge of the industry by spending time at other facilities, including Covance and Elanco, networking with executive leadership and participating in team-building activities with other summer interns across the company.
"We see a great synergy in the making, as these students will have the opportunity to obtain unique, real-world experiences in the realm of drug discovery and development and the myriad of regulatory, legal and business aspects of the pharmaceutical industry," said Dr Bryan Larsen, PhD, associate dean for biomedical sciences, Marian University College of Osteopathic Medicine. "And Marian University will enjoy an unprecedented opportunity to showcase some of its very promising student doctors to the leaders of one of the most revered pharmaceutical companies in the world," he added.
This is the second medical student program launched by Lilly this year. In February, Lilly announced a new partnership with Tulane University School of Medicine to debut the Medical Student Rotation Program, a 4-week experiential learning program for fourth-year medical students.
The 10-week internship program with Marian University students, which will run from May through August, matches interns with projects based on their skills and interests. Experienced, knowledgeable mentors will help students gain hands-on experience and explore diverse career options in healthcare.
"By participating in this program, students will gain experience in drug development, interact with professionals in a variety of medical roles, and further develop leadership skills," said Katie Sugarman, MD, Senior Director, Global Regulatory Affairs — Oncology, Eli Lilly and Company, and a Lilly mentor in the new medical student programs. "We believe this internship will provide students with a better understanding of how physicians contribute to patient outcomes in this area of healthcare."
Both the Intern Program and Medical Student Rotation Program highlight Lilly's ongoing commitment to medical education.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance